LONGEVITY

VENTURE Salon

LANSERSEE  •  AUSTRIA

23.-26. APRIL 2026

A CURATED 3-DAY SALON ON THE FUTURE OF REGENERATIVE MEDICINE, DEEP TECH AND INVESTMENT

  • "The salon concept pioneered by my friends Daniel and Tanmay harkens back to the origins of the Enlightenment and the gatherings that sparked and nurtured the intellectual curiosity behind the scientific revolution. This model is the Davos of the future."

    Shahram Seyedin-Noor Founder and Managing Partner Civilization Ventures, San Francisco

  • “The RISE Longevity Venture Salon stands out as a unique forum connecting leading voices in longevity research, venture capital, and innovation at a beautiful location. The conversations were insightful, forward-looking, and centered on accelerating meaningful progress in healthy aging. It was an inspiring meeting and I was honored to participate.”

    Dr. Morten Scheibye-Knudsen Associate Professor University of Copenhagen, co-chair, ARDD 2026 Conference

  • "The format was excellent, the group was exceptional, and the whole event felt thoughtful, intimate, and genuinely inspiring. It's impressive what you've done with the place and the quality of everything. I left with the sense that this kind of gathering could become very meaningful over time if it continues to evolve and connections deepen, resulting in real progress."

    Maria Marinova, Ph.D. Scientific Director at The Thalion Initiative

  • "Inbetween Tyrolean mountains, on a small lake, the refreshing Salon concept has been re-invented. Bringing humans together over meals, wine, and sincere discussions has been a recipe to build trust since the beginning of time, and in an era that is dominated by superficial interactions, events like this matter even more."

    Dr. Max Unfried Scientific Director at The Thalion Initiative

WHY LONGEVITY


The Asset Class of the Century. Aging BioTECH is no longer a niche; it is the inevitable future of healthcare. We are witnessing the transition from reactive 'sick care' to preventative computational biology. The next decade of healthcare will be defined by TechBio and AI-driven drug discovery—transforming aging from an inevitable decline into a treatable medical condition.

THE MARKET The global longevity economy is projected to reach $8 trillion by 2030.

THE DEMOGRAPHIC By 2050, the global population over 60 will nearly double to 2.1 billion, creating unprecedented demand for preventative and regenerative technologies.

COLLABORATORS


Markus Langes Swarovski

Reverdie GmbH - Family Office / SEGNALITA Ventures GmbH

Advisory Board


Markus Langes-Swarovski has held senior executive positions as well as various board seats within the Swarovski Group for many years. Currently he is on the Board of the Swarovski Family Holding/ Founder and Shareholder SEGNALITA Ventures GmbH / Reverdie GmbH …

Dr. Morten Scheibye-Knudsen

Associate Professor University of Copenhagen, co-chair, ARDD 2026 Conference

Keynote Speaker


Morten Scheibye-Knudsen is the president of the Nordic Aging Society, founding member of the European Federation for Aging Research, chief editor at Frontiers in Aging, co-founder of Senoscope, owner of MSK Consulting, CSO Healthy Longevity Clinic, he consults for BOLD Longevity Growth Fund and Deep Longevity, where he is a shareholder.

Shahram Seyedin-Noor

founder and GP at Civilization Ventures, serial entrepreneur

Fireside Speaker


Prior to founding CV, Shahram was founding CFO at NextBio (acquired by Illumina) and founding CEO at Inspirna. He has 20+ exits across health and biotech behind him, including BillionToOne (IPO), Omada Health (IPO), and Fluent BioHe. Shahram began his career at WSGR, Cooley and Goldman Sachs

STARTUPS


PRESS


Meet the Team

  • Mag. Daniel Rhomberg

    Mag. Daniel Rhomberg

    owner Lansersee Estate, architect, computational design

  • Mo Elzek, MD, PhD

    Mo Elzek, MD, PhD

    medical doctor turned systems biologist, Longevity Hacks, Saïd Business School, London Longevity

  • Tanmay Gupta, PhD

    Tanmay Gupta, PhD

    ex-Cambridge researcher turned entrepreneur and innovation strategist, Longevity Hacks, GetSeen Ventures, Oxbridge Frontier Intelligence

  • Cassy Le, PHD

    Cassy Le, PHD

    molecular biologist, 2060 Foundation, Nucleate, AthenaBIO, VitaDAO

ASSOCIATED ENDEAVORS